| Year |
Citation |
Score |
| 2019 |
Mansikkamäki S, Sinkkonen ST, Korpi ER, Lüddens H. Multiple actions of fenamates and other nonsteroidal anti-inflammatory drugs on GABA receptors. European Journal of Pharmacology. 853: 247-255. PMID 30930251 DOI: 10.1016/j.ejphar.2019.03.039 |
0.777 |
|
| 2010 |
Hellsten KS, Sinkkonen ST, Hyde TM, Kleinman JE, Särkioja T, Maksimow A, Uusi-Oukari M, Korpi ER. Human locus coeruleus neurons express the GABA(A) receptor gamma2 subunit gene and produce benzodiazepine binding. Neuroscience Letters. 477: 77-81. PMID 20417252 DOI: 10.1016/j.neulet.2010.04.035 |
0.788 |
|
| 2009 |
Halonen LM, Sinkkonen ST, Chandra D, Homanics GE, Korpi ER. Brain regional distribution of GABA(A) receptors exhibiting atypical GABA agonism: roles of receptor subunits. Neurochemistry International. 55: 389-96. PMID 19397945 DOI: 10.1016/J.Neuint.2009.04.008 |
0.812 |
|
| 2007 |
Saarelainen KS, Ranna M, Rabe H, Sinkkonen ST, Möykkynen T, Uusi-Oukari M, Linden AM, Lüddens H, Korpi ER. Enhanced behavioral sensitivity to the competitive GABA agonist, gaboxadol, in transgenic mice over-expressing hippocampal extrasynaptic alpha6beta GABA(A) receptors. Journal of Neurochemistry. 105: 338-50. PMID 18021290 DOI: 10.1111/j.1471-4159.2007.05136.x |
0.786 |
|
| 2007 |
Möykkynen TP, Sinkkonen ST, Korpi ER. Compensation by reduced L-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor responses in a mouse model with reduced gamma-aminobutyric acid type A receptor-mediated synaptic inhibition. Journal of Neuroscience Research. 85: 668-72. PMID 17131399 DOI: 10.1002/jnr.21138 |
0.746 |
|
| 2006 |
Ranna M, Sinkkonen ST, Möykkynen T, Uusi-Oukari M, Korpi ER. Impact of epsilon and theta subunits on pharmacological properties of alpha3beta1 GABAA receptors expressed in Xenopus oocytes. Bmc Pharmacology. 6: 1. PMID 16412217 DOI: 10.1186/1471-2210-6-1 |
0.771 |
|
| 2006 |
Sinkkonen ST, Rabe H, Lüddens H, Korpi ER. Evidence for a reduction of coupling between GABAA receptor agonist and ionophore binding sites by inorganic phosphate. Neurochemical Research. 30: 1471-82. PMID 16362766 DOI: 10.1007/s11064-005-8824-x |
0.754 |
|
| 2005 |
Korpi ER, Sinkkonen ST. GABA(A) receptor subtypes as targets for neuropsychiatric drug development. Pharmacology & Therapeutics. 109: 12-32. PMID 15996746 DOI: 10.1016/j.pharmthera.2005.05.009 |
0.78 |
|
| 2004 |
Sinkkonen ST, Vekovischeva OY, Möykkynen T, Ogris W, Sieghart W, Wisden W, Korpi ER. Behavioural correlates of an altered balance between synaptic and extrasynaptic GABAAergic inhibition in a mouse model. The European Journal of Neuroscience. 20: 2168-78. PMID 15450096 DOI: 10.1111/J.1460-9568.2004.03684.X |
0.8 |
|
| 2004 |
Sinkkonen ST, Lüscher B, Lüddens H, Korpi ER. Autoradiographic imaging of altered synaptic alphabetagamma2 and extrasynaptic alphabeta GABAA receptors in a genetic mouse model of anxiety. Neurochemistry International. 44: 539-47. PMID 15209422 DOI: 10.1016/J.Neuint.2003.08.008 |
0.816 |
|
| 2004 |
Sinkkonen ST, Lindén AM, Korpi ER, Wong G. Selective reduction of gamma-aminobutyric acid type A receptor delta subunit mRNA levels by MK-801 in rat dentate gyrus. Neuroscience Letters. 364: 106-9. PMID 15196688 DOI: 10.1016/j.neulet.2004.04.022 |
0.734 |
|
| 2003 |
Sinkkonen ST, Mansikkamäki S, Möykkynen T, Lüddens H, Uusi-Oukari M, Korpi ER. Receptor subtype-dependent positive and negative modulation of GABA(A) receptor function by niflumic acid, a nonsteroidal anti-inflammatory drug. Molecular Pharmacology. 64: 753-63. PMID 12920213 DOI: 10.1124/mol.64.3.753 |
0.795 |
|
| Show low-probability matches. |